ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug safety Update MHRA February 2019.pdf

Drug safety Update MHRA February 2019.pdf
Summary: Carbimazole: increased risk of congenital malformations; strengthened advice on contraception. Carbimazole: increased risk of Pancreatitis. SGLT2 inhibitors: reports of Fournier's gangrene.
File Size: 219KB
File Type: application/pdf
Created: 18 February 2019
Last Modified: 25 April 2019